LMD in Sodium Chloride (Hospira, Inc.)


Welcome to the PulseAid listing for the LMD in Sodium Chloride drug offered from Hospira, Inc.. This Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Hospira, Inc.
NON-PROPRIETARY NAME: DEXTRAN 40
SUBSTANCE NAME: DEXTRAN 40
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1992-10-30
END MARKETING DATE: 0000-00-00


LMD in Sodium Chloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLMD in Sodium Chloride from Hospira, Inc.
LABELER NAME: Hospira, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(g/100mL)
START MARKETING DATE: 1992-10-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0409-7419_d73450a5-90e4-4fd4-aa0e-44d4dcbd6c17
PRODUCT NDC: 0409-7419
APPLICATION NUMBER: BA720562

Other DEXTRAN 40 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hospira, Inc.LMD in Dextrose